Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb;11(1):56-61.
doi: 10.1093/ckj/sfx063. Epub 2017 Jul 17.

Causes and predictors of mortality in biopsy-proven lupus nephritis: the Sarawak experience

Affiliations

Causes and predictors of mortality in biopsy-proven lupus nephritis: the Sarawak experience

Cheng Lay Teh et al. Clin Kidney J. 2018 Feb.

Abstract

Background: Lupus nephritis (LN) is a serious manifestation of systemic lupus erythematosus that can be fatal if left untreated. The causes and prognostic predictors of mortality in LN have been well studied in developed countries but evidence is lacking for developing countries. The objective of this study was to investigate the causes and predictors of mortality in a cohort of Malaysian patients with biopsy-proven LN.

Methods: We retrospectively studied all patients with biopsy-proven LN treated in Sarawak General Hospital during the period of 2000-15. Demographic data, clinical features and outcomes were collected. Cox regression analysis was carried out to determine the independent predictors of mortality.

Results: There was a total of 250 patients with 259 renal biopsies available for our analysis. Our patients were of multi-ethnic origins with a female predominance (90%). Their mean ± standard deviation age was 37.7 ± 12.8 years. The patients had a mean disease duration of 135.6 ± 81.9 months. Nephrotic syndrome was the most common presentation (29.6%) and acute renal failure was evident at initial presentation in 16% of patients. Class IV LN was the predominant biopsy class within the cohort (66.8%). The majority of patients achieved remission (81.2%) and had normal renal function (83.9%) at the last follow-up. The 5-, 10-, 15- and 20-year survival rates for our cohort were 93%, 88%, 82% and 77%, respectively. There were 37 deaths (14.8%), of which the main causes were: infection and flare (52.7%), infection alone (25.0%) and other causes (22.3%). Independent predictors of mortality in our cohort of LN patients were: the presence of acute kidney injury at presentation [hazard ratio (HR) 3.41; confidence interval (CI) 1.50-7.76], failure to achieve remission at 1-year post-induction therapy (HR 2.99; CI 1.35-6.65) and non-compliance with treatment (HR 1.89; CI 1.22-2.96). Age, ethnicity, class of LN and type of immunosuppressant used were not predictive of mortality.

Conclusions: Survival and renal outcomes in our LN cohort were comparable to most LN studies reported worldwide. Both flare and infection remained the main causes of death. The presence of acute renal failure at presentation, failure to achieve remission at 1 year post-treatment and non-compliance with treatment were independent prognostic predictors of mortality in LN.

Keywords: dialysis; lupus nephritis; mortality; outcome; systemic lupus erythematosus.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Survival patterns according to the status of renal function at presentation.
Fig. 2.
Fig. 2.
Renal survival patterns according to remission status at 1 year post-induction therapy.

References

    1. Golbus J, McCune WJ. Lupus nephritis: classification, prognosis, immunopathogenesis, and treatment. Rheum Dis Clin North Am 1994; 20: 213–242 - PubMed
    1. Maroz N, Segal MS.. Lupus nephritis and end-stage kidney disease. Am J Med Sci 2013; 346: 319–323 - PubMed
    1. Ortega LM, Schultz DR, Lenz O. et al. Review: lupus nephritis: pathologic features, epidemiology and aguide to therapeutic decisions. Lupus 2010; 19: 557–574 - PubMed
    1. Cameron JS. Lupus nephritis. J Am Soc Nephrol 1999; 10: 413–424 - PubMed
    1. Ippolito A, Petri M.. An update on mortality in systemic lupus erythematosus. Clin Exp Rheumatol 2008; 26: S72–S79 - PubMed

LinkOut - more resources